FBR Capital Starts Spectrum Pharmaceuticals (SPPI) at Outperform
Tweet Send to a Friend
FBR Capital initiates coverage on Spectrum Pharmaceuticals (NASDAQ: SPPI) with a Outperform rating and a price target of $9.00.Analyst Ed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE